Litman Gregory Wealth Management LLC Cuts Stake in UnitedHealth Group Incorporated $UNH

Litman Gregory Wealth Management LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 14.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 23,660 shares of the healthcare conglomerate’s stock after selling 3,904 shares during the period. Litman Gregory Wealth Management LLC’s holdings in UnitedHealth Group were worth $7,381,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in UNH. D.B. Root & Company LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth $528,000. Comprehensive Financial Consultants Institutional Inc. increased its holdings in UnitedHealth Group by 59.1% in the 2nd quarter. Comprehensive Financial Consultants Institutional Inc. now owns 6,836 shares of the healthcare conglomerate’s stock worth $2,133,000 after buying an additional 2,540 shares in the last quarter. Belpointe Asset Management LLC lifted its stake in UnitedHealth Group by 22.5% during the 2nd quarter. Belpointe Asset Management LLC now owns 11,165 shares of the healthcare conglomerate’s stock valued at $3,484,000 after acquiring an additional 2,051 shares during the period. Duncan Williams Asset Management LLC grew its stake in shares of UnitedHealth Group by 45.3% in the second quarter. Duncan Williams Asset Management LLC now owns 4,246 shares of the healthcare conglomerate’s stock worth $1,325,000 after acquiring an additional 1,324 shares during the period. Finally, Appleton Partners Inc. MA lifted its position in UnitedHealth Group by 36.5% during the second quarter. Appleton Partners Inc. MA now owns 50,378 shares of the healthcare conglomerate’s stock valued at $15,717,000 after purchasing an additional 13,458 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.8%

UNH opened at $360.17 on Monday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. The firm’s fifty day moving average is $307.84 and its 200 day moving average is $353.45.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UNH. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. Oppenheimer dropped their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.